Similar articles

• Crescentic glomerulonephritis--which patients should be treated with plasma exchange?

  Bell GM, Cumming AD, Swainson CP, Winney RJ, Robson JS. Bell GM, et al. Life Support Syst. 1983;1 Suppl 1:92-4. Life Support Syst. 1983. PMID: 6336470 No abstract available.
• Treatment and prognosis in antibasement membrane antibody-mediated nephritis.

  Peters DK, Rees AJ, Lockwood CM, Pusey CD. Peters DK, et al. Transplant Proc. 1982 Sep;14(3):513-21. Transplant Proc. 1982. PMID: 7179435 No abstract available.
• [Nephrology update--IV. Rapidly progressing glomerulonephritis].

  Fünfstück R, Stein G. Fünfstück R, et al. Med Klin (Munich). 1996 Oct 15;91(10):632-9. Med Klin (Munich). 1996. PMID: 9019640 Review. German. No abstract available.
• Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritis.

  Pusey CD, Lockwood CM. Pusey CD, et al. Prog Clin Biol Res. 1982;106:91-104. Prog Clin Biol Res. 1982. PMID: 6757955 No abstract available.
• Plasma exchange in glomerulonephritis and related vasculitides.

  Lockwood CM, Peters DK. Lockwood CM, et al. Annu Rev Med. 1980;31:167-79. doi: 10.1146/annurev.me.31.020180.001123. Annu Rev Med. 1980. PMID: 6994604 Review. No abstract available.